Baxalta Inc Patent Applications Rejected
6 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2017-11-18: Application 15575356; Invention ANTI-MIF ANTIBODIES IN THE TREATMENT OF CANCERS CONTAINING MUTANT TP53 AND/; Applicant Baxalta Incorporated; Status Abandoned -- Incomplete Application (Pre-examination).
- 2017-03-27: Application 15470064; Invention VIRUS FILTRATION OF CELL CULTURE MEDIA; Applicant BAXALTA INCORPORATED; Status Abandoned -- Failure to Respond to an Office Action.
- 2017-01-18: Application 15409032; Invention RECOMBINANT CO-EXPRESSION OF VITAMIN K EPOXIDE REDUCTASE SUBUNIT 1 TO IMPROVE VITAMIN K DEPENDENT PROTEIN EXPRESSION; Applicant Baxalta Incorporated; Status Abandoned -- Failure to Respond to an Office Action.
- 2016-06-10: Application 15179343; Invention Method of Administering Porcine B-Domainless fVIII; Applicant Baxalta Incorporated; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2017-11-18 | 15575356 | ANTI-MIF ANTIBODIES IN THE TREATMENT OF CANCERS CONTAINING MUTANT TP53 AND/ | Baxalta Incorporated Baxalta GmbH | Abandoned -- Incomplete Application (Pre-examination) | US20180155419A1 | Patrice Douillard Randolf Kerschbaumer Michael Thiele Salim Yazji | Austria Austria Austria United States | |
| 2017-03-27 | 15470064 | VIRUS FILTRATION OF CELL CULTURE MEDIA | BAXALTA INCORPORATED BAXALTA GMBH | Abandoned -- Failure to Respond to an Office Action | US20170260498A1 | Wolfgang MUNDT Artur MITTERER Manfred REITER Meinhard HASSLACHER Leopold GRILLBERGER Thomas KREIL | Austria Austria Austria Austria Austria Austria | LANKFORD JR, LEON B |
| 2017-01-18 | 15409032 | RECOMBINANT CO-EXPRESSION OF VITAMIN K EPOXIDE REDUCTASE SUBUNIT 1 TO IMPROVE VITAMIN K DEPENDENT PROTEIN EXPRESSION | Baxalta Incorporated Baxalta GmbH | Abandoned -- Failure to Respond to an Office Action | US20170226487A1 | Friedrich Scheiflinger Ernst Boehm | Austria Austria | ROBINSON, HOPE A |
| 2016-06-10 | 15179343 | Method of Administering Porcine B-Domainless fVIII | Baxalta Incorporated Baxalta GmbH Emory University | Abandoned -- Failure to Respond to an Office Action | US20170119857A1 | John S. LOLLAR Garrett E. BERGMAN | United States United States | HOLLAND, PAUL J |
| 2015-06-22 | 14746121 | VITAMIN K EPOXIDE RECYCLING POLYPEPTIDE VKORC1, A THERAPEUTIC TARGET OF COUMARIN AND THEIR DERIVATIVES | Baxalta Incorporated Baxalta GmbH | Abandoned -- Failure to Respond to an Office Action | US20170240867A1 | Johannes OLDENBURG Clemens R. MUELLER-REIBLE Andreas FREGIN Simone ROST Tim-Matthias STROM | Germany Germany Germany Germany Germany | CHOWDHURY, IQBAL HOSSAIN |
| 2014-01-17 | 14157967 | ANTI MIF ANTIBODIES | Baxalta Incorporated Dyax Corp. Baxalta GmbH | Abandoned -- Failure to Pay Issue Fee | US20150023978A1 | Randolf Kerschbaumer Friedrich Scheiflinger Manfred Rieger Michael Thiele Geert C. Mudde Juergen Muellberg Rene Hoet | Austria Austria Austria Austria Austria United States Netherlands | KEMMERER, ELIZABETH |